Skip to main content
TipRanks
Go Ultimate75% OFF

Kenneth Attie Insider Profile

4 Followers

Kenneth Attie, SVP, CMO at Enliven Therapeutics, holds 34.10K shares in Enliven Therapeutics (Ticker: ELVN).

Kenneth Attie's Trading History

ELVN
Enliven Therapeutics
Feb 01, 2022SVP, CMOUninformative Buy―$1.62M
ELVN
Insider Shares: 34.10K (0.00%)

Kenneth Attie has not reported any informative transactions for ELVN, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 01, 2022Uninformative Buy$0.0034,100$0.00―

You May Also Like

Kenneth Attie insider profile FAQ

What stocks does Kenneth Attie hold?
Kenneth Attie holds: ELVN stocks.
What is Kenneth Attie's role in Enliven Therapeutics?
Kenneth Attie's role in Enliven Therapeutics is SVP, CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.